A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD

Recruiting

Phase 3

LPCN 1154AA Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD

Sponsor:

Lipocine Inc.

Code:

NCT06979544

Conditions

Depression, Postpartum

Depression, Post-Partum

Postpartum Depression (PPD)

Post-Natal Depression

Peripartum Depression

Eligibility Criteria

Sex: Female

Age: 15 - 45

Healthy Volunteers: Not accepted

Interventions

LPCN 1154A

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-30. This information was provided to ClinicalTrials.gov by Lipocine Inc. on 2025-08-12.